Sastasundar Ventures Ltd

AGM Details

• AGM held on 28 September 2026 with remote e-voting facility.
• Cut-off date for voting rights: 21 September 2026.
• Mode: physical meeting with remote e-voting facility.
• Annexures on voting results and scrutinizer's report issued; results hosted online.

Resolutions Put to Vote

• Item 1: Ordinary—receive, consider, and adopt Standalone and Consolidated financial statements.
• Item 2: Ordinary—appoint Abha Mittal by rotation.
• Item 3: Special—re-appoint Anjana Dikshit as Independent Director for second term.
• Item 4: Special—approve overall borrowing limit under Section 180(1)(c).
• Item 5: Special—approve creation of mortgage/charge on assets.
• Item 6: Special—approve investments in securities under Section 186.
• Item 7: Special—approve loans/guarantees/security under Section 185.

Voting Results

• Item 1 passed; 99.9996% in favour, 0.0004% against.
• Item 2 passed; 99.9996% in favour, 0.0004% against.
• Item 3 passed; 99.9996% in favour, 0.0004% against.
• Item 4 passed; 99.9996% in favour, 0.0004% against.
• Item 5 passed; 99.9996% in favour, 0.0004% against.
• Item 6 passed; 99.9996% in favour, 0.0004% against.
• Item 7 passed; 99.9996% in favour, 0.0004% against.

Directors & Management Changes

• Anjana Dikshit appointed Independent Director for second term, Nov 10, 2026 to Nov 9, 2031.
• Abha Mittal re-appointed by rotation as Director.

Auditors

• Auditors to continue for standalone and consolidated audits.

Other Material Approvals

• Borrowing limit approved under Section 180(1)(c).
• Creation of mortgage/charge on assets approved under Section 180(1)(a).
• Investments in securities approved under Section 186.
• Advances/loans/guarantees/security approvals under Section 185.

AGM Details

• AGM held on 28 September 2026 at 3:00 PM IST via VC/OAVM.
• 104 members attended the meeting.
• Remote e-voting: 25–27 September 2026.
• Chairman: Mr. B. L. Mittal.
• Platform: Instameet provided by MUFG Intime India.
• Notice dated 7 August 2026.

Key Resolutions

• Ordinary resolution: adopt audited standalone and consolidated financial statements for year ended 31 March 2026.
• Ordinary resolution: re-appoint director retiring by rotation (Mrs Abha Mittal).
• Special resolution: re-appoint Anjana Dikshit as independent director for second five-year term.
• Special resolution: approve overall borrowing limit under Section 180(1)(c).
• Special resolution: approve mortgage/charge on assets under Section 180(1)(a).
• Special resolution: approve loans, guarantees, security and investments under Section 186.
• Special resolution: approve advances/loans under Section 185.

Voting Results

• Voting results not disclosed; to be announced on exchanges within two working days.

Director Changes

• Abha Mittal retires by rotation and seeks re-appointment.
• Anjana Dikshit appointed as independent director for second term.

Auditors

• No auditor appointment changes disclosed.

Material Related Party Transactions

• No material RPTs disclosed in this filing.

Other Material Approvals

• Composite Scheme of Arrangement and Amalgamation among Health X, MRPL, ITL, SHBL; approvals pending.

Health X Platform Ltd trading window closed from 1 October 2026 till 48 hours after the declaration of unaudited financial results for the quarter and half year ended 30 September 2026

AGM Details

• The 37th AGM will be held on 28 September 2026 at 3:00 PM IST via VC/OAVM.
• Annual Report for FY ended 31 March 2026 will be submitted in due course.

Meeting Details

• Date and time: Aug 31, 2026, 2:00 PM IST to 3:30 PM IST
• Type and mode: Group conference, physical venue at Jio World Convention Centre, Mumbai
• Event: GIA Healthcare Day

Participants

• Company representatives attending; specific names not disclosed
• Roles: Company Secretary & Compliance Officer mentioned

Purpose

• Purpose: investor/analyst interaction with Health X Platform Ltd

Additional Notes

• Schedule subject to change; no unpublished information disclosed

Financial Performance

• Revenue from operations grew >58% YoY to INR 440 crores; QoQ +16% to INR 378 crores.
• Gross profit INR 34 crores; up 64% YoY; up 24% QoQ.
• Gross margin 7.8%, up from 7.3% in Q4 FY26.
• EBITDA loss narrowed to INR 15 crores; EBITDA margin -3.4%.
• PAT stood at INR 2 crores.
• Working capital cycle ~28 days; ~8% of revenue.
• July revenue ended at INR 150 crores.
• Tier-2/3 markets: RetailerShakti 67%; SastaSundar 78%.
• West Bengal contributes ~30% of RetailerShakti revenue.
• JITO revenue: Q4 FY26 INR 25 lakhs; current quarter INR 79 lakhs; 200% growth.
• RetailerShakti orders: 69.4% above 2,500; 42.4% above 5,000.
• SastaSundar orders: 69.2% above 1,000; 30.8% below 1,000.
• Healthbuddy to JITO conversions: 19; 25 in pipeline; ~50% in 3 months.

Operations and Geography

• Geography expansion: Odisha, Jharkhand, Bihar; Noida northern expansion.
• Approximately 67% of RetailerShakti and 78% of SastaSundar from tier-2/3 markets.
• Northeast is highest growth region; Jharkhand shows strongest growth.

Projects and Capex

• Noida warehouse completed; new Noida site operational by Aug 17.
• Guwahati expansion: 75,000 sq ft; expansion underway.
• Ranchi, Patna, Chhattisgarh ramp-ups planned this year.
• Plan to own logistics; minimize reliance on external warehouses.
• Warehouse capacity expansion aimed to support INR 2,500–3,000 crores revenue next year.

Q&A Highlights

• RetailerShakti gross margin ~7.8%; EBITDA near break-even; positive EBITDA targeted in Q3 FY27.
• Consolidated gross margin target around 12% long-term; current year 8%+ gross margin guidance.
• July run-rate ~INR 150 crores; not a formal annual forecast.
• West Bengal ~30% of RetailerShakti revenue; Northeast growth strongest; Jharkhand fastest growth.
• JITO conversions: 19 Healthbuddies converted; 25 in pipeline; ~50% in 3 months.
• SastaSundar/HealthBuddy burn funded by technology and brand investments; EBITDA not a near-term focus.

Outlook and Guidance

• FY27 to be an important year with growth momentum; profitability and capital efficiency focus.
• AI RetailAir launch scheduled this quarter; success to be confirmed next quarter.
• Strategy emphasizes expanding across geographies, deepening technology, and scaling RetailerShakti and SastaSundar.

Meeting Details

• Date and time: 11 August 2026, 4:00 PM IST; earnings conference call (virtual)

Participants

• Senior Management attended; discussed performance for quarter ended June 30, 2026 and updates

Purpose

• Purpose: discuss quarterly results and company updates with Q&A

Additional Notes

• Audio recording of the Q1 FY27 call has been made available on the company's website